He J, Yang W, Quan W, Yang Y, Zhang Z, Luo Q
RSC Adv. 2024; 14(52):38480-38490.
PMID: 39640527
PMC: 11618533.
DOI: 10.1039/d4ra04987j.
Tian M, Dong B, Li W, Wang L, Yu H
Pharmaceutics. 2024; 16(10).
PMID: 39458667
PMC: 11511338.
DOI: 10.3390/pharmaceutics16101339.
Li R, Ng T, Garlin M, Weissleder R, Miller M
Adv Funct Mater. 2024; 30(37).
PMID: 38545084
PMC: 10972611.
DOI: 10.1002/adfm.201910369.
Wegierak D, Cooley M, Perera R, Wulftange W, Gurkan U, Kolios M
IEEE Trans Med Imaging. 2024; 43(6):2370-2380.
PMID: 38329864
PMC: 11234354.
DOI: 10.1109/TMI.2024.3364076.
Liu Z, Lv Q, Lee C, Shen L
Heliyon. 2023; 9(9):e19585.
PMID: 37809802
PMC: 10558834.
DOI: 10.1016/j.heliyon.2023.e19585.
Ultrasound contrast agents from microbubbles to biogenic gas vesicles.
Zeng W, Yue X, Dai Z
Med Rev (2021). 2023; 3(1):31-48.
PMID: 37724107
PMC: 10471104.
DOI: 10.1515/mr-2022-0020.
Exploring the potential of contrast agents in breast cancer echography: current state and future directions.
Monzeglio O, Melissa V, Rodolfi S, Valentini E, Carriero A
J Ultrasound. 2023; 26(4):749-756.
PMID: 37566194
PMC: 10632334.
DOI: 10.1007/s40477-023-00809-0.
High Contrast Detection of Carotid Neothrombus with Strong Near-Infrared Absorption Selenium Nanosphere Enhanced Photoacoustic Imaging.
He F, Hou W, Lan Y, Gao W, Zhou M, Li J
Int J Nanomedicine. 2023; 18:4043-4054.
PMID: 37520300
PMC: 10377622.
DOI: 10.2147/IJN.S404743.
Novel ultrasound techniques in the identification of vulnerable plaques-an updated review of the literature.
Yao Y, Zhang P
Front Cardiovasc Med. 2023; 10:1069745.
PMID: 37293284
PMC: 10244552.
DOI: 10.3389/fcvm.2023.1069745.
Exosomes and ultrasound: The future of theranostic applications.
Sridharan B, Lim H
Mater Today Bio. 2023; 19:100556.
PMID: 36756211
PMC: 9900624.
DOI: 10.1016/j.mtbio.2023.100556.
Role of Surface Charge of Nanoscale Ultrasound Contrast Agents in Complement Activation and Phagocytosis.
Zhou J, Xiang H, Huang J, Zhong Y, Zhu X, Xu J
Int J Nanomedicine. 2022; 17:5933-5946.
PMID: 36506344
PMC: 9733633.
DOI: 10.2147/IJN.S364381.
Nanoscale Contrast Agents for Ultrasound Imaging of Musculoskeletal System.
Tang X, Zhao M, Li W, Zhao J
Diagnostics (Basel). 2022; 12(11).
PMID: 36359426
PMC: 9689263.
DOI: 10.3390/diagnostics12112582.
Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles.
Zhao P, Zhao S, Zhang J, Lai M, Sun L, Yan F
Pharmaceutics. 2022; 14(9).
PMID: 36145646
PMC: 9505504.
DOI: 10.3390/pharmaceutics14091898.
Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging.
Wu M, Guo Y, Wei S, Xue L, Tang W, Chen D
J Nanobiotechnology. 2022; 20(1):374.
PMID: 35953871
PMC: 9367160.
DOI: 10.1186/s12951-022-01566-8.
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging.
Jugniot N, Massoud T, Dahl J, Paulmurugan R
J Nanobiotechnology. 2022; 20(1):267.
PMID: 35689262
PMC: 9185914.
DOI: 10.1186/s12951-022-01484-9.
Indocyanine green conjugated lipid microbubbles as an ultrasound-responsive drug delivery system for dual-imaging guided tumor-targeted therapy.
Li Y, Huang W, Li C, Huang X
RSC Adv. 2022; 8(58):33198-33207.
PMID: 35548112
PMC: 9086377.
DOI: 10.1039/c8ra03193b.
Acoustics at the nanoscale (nanoacoustics): A comprehensive literature review.: Part II: Nanoacoustics for biomedical imaging and therapy.
Peng C, Chen M, Spicer J, Jiang X
Sens Actuators A Phys. 2021; 332(Pt 2).
PMID: 34937992
PMC: 8691754.
DOI: 10.1016/j.sna.2021.112925.
Nanosized Contrast Agents in Ultrasound Molecular Imaging.
Zeng F, Du M, Chen Z
Front Bioeng Biotechnol. 2021; 9:758084.
PMID: 34912789
PMC: 8666542.
DOI: 10.3389/fbioe.2021.758084.
Application of ultrasound molecular imaging based on compressed sensing reconstruction algorithm to phase change drug-loaded PLGA nanoparticles targeting breast cancer MCF-7 Cells.
You Y, Cheng W, Chen H
Pak J Med Sci. 2021; 37(6):1610-1614.
PMID: 34712292
PMC: 8520378.
DOI: 10.12669/pjms.37.6-WIT.4852.
Preparation and evaluation of ultrasound-mediated dual-targeted theragnostic systems utilising phase-changeable polymeric nanodroplets on the integrin α β overexpressed breast cancer.
Li N, Duan S, Wang Y, Zhang L, Chen Y, Zhang J
Clin Transl Med. 2021; 11(10):e607.
PMID: 34709751
PMC: 8516363.
DOI: 10.1002/ctm2.607.